ATE110963T1 - Mittel zur hemmung der alpha-amylase aktivität. - Google Patents

Mittel zur hemmung der alpha-amylase aktivität.

Info

Publication number
ATE110963T1
ATE110963T1 AT90107475T AT90107475T ATE110963T1 AT E110963 T1 ATE110963 T1 AT E110963T1 AT 90107475 T AT90107475 T AT 90107475T AT 90107475 T AT90107475 T AT 90107475T AT E110963 T1 ATE110963 T1 AT E110963T1
Authority
AT
Austria
Prior art keywords
tea
agents
theaflavin
amylase activity
inhibiting alpha
Prior art date
Application number
AT90107475T
Other languages
English (en)
Inventor
Yukihiko Hara
Miwa Honda
Original Assignee
Mitsui Norin Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Norin Kk filed Critical Mitsui Norin Kk
Application granted granted Critical
Publication of ATE110963T1 publication Critical patent/ATE110963T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
  • Tea And Coffee (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT90107475T 1989-10-19 1990-04-19 Mittel zur hemmung der alpha-amylase aktivität. ATE110963T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1270228A JP3018013B2 (ja) 1989-10-19 1989-10-19 α―アミラーゼ活性阻害剤

Publications (1)

Publication Number Publication Date
ATE110963T1 true ATE110963T1 (de) 1994-09-15

Family

ID=17483335

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90107475T ATE110963T1 (de) 1989-10-19 1990-04-19 Mittel zur hemmung der alpha-amylase aktivität.

Country Status (7)

Country Link
EP (1) EP0423419B1 (de)
JP (1) JP3018013B2 (de)
KR (1) KR0178522B1 (de)
AT (1) ATE110963T1 (de)
AU (1) AU628514B2 (de)
CA (1) CA2014971C (de)
DE (1) DE69012268T2 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
JPH04253918A (ja) * 1991-02-05 1992-09-09 Mitsui Norin Kk 血糖上昇抑制剤
FR2788438B1 (fr) * 1999-01-14 2003-10-03 Arkopharma Laboratoires Composition pour le traitement de l'obesite et procede de traitement esthetique
CA2402893C (en) * 2000-03-10 2011-01-18 Kabushiki Kaisha Yakult Honsha .alpha.-amylase activity inhibitor
JP2011105763A (ja) * 2000-06-21 2011-06-02 Kao Corp Ppar依存的遺伝子転写活性化剤
WO2002009734A1 (fr) * 2000-08-01 2002-02-07 Oryza Oil & Fat Chemical Co.,Ltd. Inhibiteurs d'absorption de sucre et leur procede de production
JP4727790B2 (ja) * 2000-08-02 2011-07-20 グンゼ株式会社 抗肥満剤
DE60109955T2 (de) 2000-11-17 2006-02-16 Kao Corp. Verpackte getränke
KR20030025200A (ko) * 2001-09-19 2003-03-28 (주)바이오니아 아밀라제의 활성을 억제할 수 있는 옥수수 추출물, 이를함유하는 비만증 또는 당뇨병 치료 또는 예방용 의약적조성물 및 식품 첨가물 그리고 그들의 제조방법
JP3403400B1 (ja) 2001-09-28 2003-05-06 花王株式会社 容器詰飲料
JP3378577B1 (ja) 2001-09-28 2003-02-17 花王株式会社 飲 料
AU2002365415C1 (en) * 2001-11-28 2008-12-11 Nashai Biotech, Llc Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
US7157493B2 (en) 2001-11-28 2007-01-02 Nashai Biotech, Llc Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof
FR2836336B1 (fr) * 2002-02-26 2004-08-27 Diana Ingredients Utilisation dans un traitement cosmetique d'une fraction phenolique riche en dihydrochalcones
FR2836337B1 (fr) * 2002-02-28 2004-11-19 Bio Serae Laboratoires Utilisation des polymeres procyanidoliques a titre d'agents inhibuteurs des alpha-amylases et application dans des compositions a visees dietetiques
WO2004037022A1 (ja) 2002-10-28 2004-05-06 Kao Corporation カフェイン含有カテキン類組成物の脱カフェイン方法
JP2006508096A (ja) * 2002-11-07 2006-03-09 ディーエスエム アイピー アセッツ ビー.ブイ. 没食子酸エピガロカテキンを含む新規な栄養補助組成物
JP4776149B2 (ja) * 2003-03-28 2011-09-21 クラシエフーズ株式会社 糖質吸収抑制剤および食品
US7220444B2 (en) 2003-09-26 2007-05-22 Kao Corporation Packaged beverages
JP3597857B2 (ja) 2003-10-31 2004-12-08 花王株式会社 容器詰茶飲料
DE602004028647D1 (de) 2003-12-02 2010-09-23 Kao Corp Verpacktes getränk
JP3766670B2 (ja) 2003-12-16 2006-04-12 花王株式会社 容器詰飲料
CN100553467C (zh) 2003-12-18 2009-10-28 花王株式会社 容器装饮料
JP3597859B2 (ja) 2003-12-22 2004-12-08 花王株式会社 容器詰緑茶飲料及びその製造法
JP2006016367A (ja) * 2004-07-05 2006-01-19 Suntory Ltd リパーゼ阻害剤
JP3742096B1 (ja) * 2005-02-08 2006-02-01 花王株式会社 非茶系容器詰飲料
JP3742094B1 (ja) * 2004-11-04 2006-02-01 花王株式会社 非茶系容器詰飲料
KR20070026005A (ko) * 2005-09-01 2007-03-08 카오카부시키가이샤 정제 녹차 추출물의 제조 방법
JP4884003B2 (ja) 2005-12-27 2012-02-22 花王株式会社 容器詰烏龍茶飲料
US9808023B2 (en) 2006-03-02 2017-11-07 Kao Corporation Process for producing purified tea extract
JP4569965B2 (ja) 2006-04-17 2010-10-27 花王株式会社 精製緑茶抽出物の製造法
JP4562682B2 (ja) 2006-04-17 2010-10-13 花王株式会社 精製緑茶抽出物の製造法
JP5080835B2 (ja) 2006-07-04 2012-11-21 花王株式会社 発泡性容器詰飲料
JP2008088146A (ja) 2006-09-08 2008-04-17 Kao Corp インスリン感受性改善剤
EP2098121B1 (de) 2006-12-22 2013-09-18 Kao Corporation Containerverpacktes grünteegetränk
US9414613B2 (en) 2006-12-28 2016-08-16 Kao Corporation Tea extract
US20100104724A1 (en) * 2007-01-24 2010-04-29 Kao Corporation Confectionery
JP2008200032A (ja) 2007-01-24 2008-09-04 Kao Corp パン類
KR101463639B1 (ko) 2007-05-08 2014-12-04 카오카부시키가이샤 환원 음료용 농축 조성물
JP5517412B2 (ja) 2007-05-24 2014-06-11 花王株式会社 精製緑茶抽出物
KR101475758B1 (ko) 2007-08-08 2014-12-23 가오 가부시키가이샤 차 추출물의 제조방법
WO2009028211A1 (ja) 2007-08-30 2009-03-05 Kao Corporation インスタント粉末飲料
US8445031B2 (en) 2007-09-05 2013-05-21 Kao Corporation Method for producing purified tea extract
JP2009268420A (ja) * 2008-05-09 2009-11-19 Kataoka & Co Ltd 機能性食品組成物
JP2010222277A (ja) * 2009-03-23 2010-10-07 Kao Corp 食後の血糖値上昇抑制剤
JP2011182703A (ja) * 2010-03-08 2011-09-22 Asahi Group Holdings Ltd 1,2−ジ−O−ガロイル−4,6−HHDP−b−d−グルコピラノースを高濃度で含有する飲食品
JP5744507B2 (ja) * 2010-12-24 2015-07-08 三井農林株式会社 α−アミラーゼ阻害剤
JP6353034B2 (ja) * 2014-04-23 2018-07-04 日本製紙株式会社 糖尿病予防または改善剤
JP6355129B2 (ja) * 2014-11-06 2018-07-11 国立研究開発法人農業・食品産業技術総合研究機構 1,2−ジ−O−ガロイル−4,6−HHDP−b−d−グルコピラノースを高濃度で含有する飲食品
US20190328020A1 (en) 2016-12-21 2019-10-31 Suntory Holdings Limited Food and beverages containing epigallocatechin gallate and cyclo(prolyl-threonine)
CN117042632A (zh) 2021-03-22 2023-11-10 花王株式会社 含有儿茶素类的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
JPS63214183A (ja) * 1987-03-03 1988-09-06 Mitsui Norin Kk アンジオテンシン1変換酵素阻害剤
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤

Also Published As

Publication number Publication date
AU5319590A (en) 1991-04-26
JP3018013B2 (ja) 2000-03-13
DE69012268T2 (de) 1995-02-23
DE69012268D1 (de) 1994-10-13
EP0423419B1 (de) 1994-09-07
JPH03133928A (ja) 1991-06-07
AU628514B2 (en) 1992-09-17
CA2014971C (en) 1999-12-14
KR0178522B1 (ko) 1999-03-20
CA2014971A1 (en) 1991-04-19
KR910007538A (ko) 1991-05-30
EP0423419A1 (de) 1991-04-24

Similar Documents

Publication Publication Date Title
ATE110963T1 (de) Mittel zur hemmung der alpha-amylase aktivität.
EP0417385A3 (en) Preventive and curative medicament against infection with influenza virus, containing tea or tea polyphenols
DE69732402D1 (de) Zusammensetzung zur Behandlung von Kondyloma acuminata
ATE117891T1 (de) Zahnbelag verhindernde mittel.
ATE222113T1 (de) Polyphenol fraktionen von tee, ihre verwendung und diese enthaltende formulierungen
ES2177506T3 (es) Extractos de te verde que contienen catecoles y cafeina.
HK1107276A1 (en) Oral care composition containing extract of unoxidized camellia
ES2052678T3 (es) Tratamiento y post-tratamiento de metales con compuestos polifenolicos modificados con hidratos de carbono.
ES2056094T3 (es) Tratamiento y post-tratamiento de metales con compuestos polifenolicos.
ATE382343T1 (de) Polyphenole enthaltende pharmazeutische nahrungsmittelergänzungsformel und ihre anwendung in der krebsbehandlung
ATE346059T1 (de) Verfahren zu herstellung von epigallocatechin gallate
DE69317537D1 (de) Antiallergische Zusammensetzung zur ophthalmischen oder nasalen Anwendung
EP0819433A3 (de) Zusammensetzungen zur Erhöhung der Wirksamkeit von Antikrebsmittel durch Catechin aus Tee und/oder Theaflavin
KR910015293A (ko) 항생물질 내성 포도상 구균 감염예방제
ATE125694T1 (de) Glukosyltransferase-inhibitoren sowie verfahren zur vorbeugung von karies und anti-karöse nahrungsmittel mittels dieser inhibitoren.
EP0400219A3 (de) Verwendung von Creosot als antispastischer Wirkstoff
ZA916234B (en) New synergistic composition of 2-(2-bromo-2-nitroethenyl)furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof
ATE248571T1 (de) Substanz zur behandlung der alopezie
MX2021010491A (es) Tratamiento de fibromas con vitamina d y un agente tal como galato de epigalocatequina (egcg).
KR940001884A (ko) 혈당 상승 억제 방법
JPS53141223A (en) Preparation of aromatic polyamine
TH84870B (th) สารผสมดูแลเกี่ยวกับปากที่มีสิ่งสกัดของ Camellia ที่ไม่ออกซิไดซ์อยู่ด้วย

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee